Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 60% of the road = 270-days

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Jul 13, 2022 10:17am

340 Views

Post# 34820477

RE:RE:RE:RE:RE:RE:60% of the road = 270-days

You guys with spreadsheets. How many patients have reported 270 and 360 days by now? And, if possible, are you able to tell how many of these have had the optmized treatment? If I am not mistaken there should be a bunch of optimized people in the next update at these points, whenever it comes. It could hopefully change the CR quite a bit.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)